Authors: BOS GMJ VANPUTTEN WLJ VANDERHOLT B VANDENBENT M VERDONCK LF HAGENBEEK A

Citation: Gmj. Bos et al., FOR WHICH PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA IS PROPHYLAXIS FOR CENTRAL-NERVOUS-SYSTEM DISEASE MANDATORY, Annals of oncology, 9(2), 1998, pp. 191-194

Authors: PLANTING A KHO S VANDERBURG M GOEY H SCHELLENS J VANDENBENT M VANDERGAAST A DEBOERDENNERT M STOTER G VERWEIJ J

Citation: A. Planting et al., A PHASE-II STUDY OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH ORAL ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 40(4), 1997, pp. 347-352

Authors: HOANGXUAN K CHINOT O FRENAY M TAILLANDIER L HILDEBRAND J MONJOUR A VANDENBENT M SAHMOUND T POISSON M DELATTRE JY

Citation: K. Hoangxuan et al., CHEMOTHERAPY ALONE AS INITIAL TREATMENT OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL) IN OLDER PATIENTS, Neurology, 48(3), 1997, pp. 1001-1001

Authors: VANDENBENT M SMITT PAES VECHT CJ

Citation: M. Vandenbent et al., FALSE-NEGATIVE SURAL NERVE BIOPSY IN NEUROLYMPHOMATOSIS, Neurology, 48(3), 1997, pp. 1015-1015

Authors: JANSEN B PILLAY M DEBRUIN H VANDENBENT M VECHT CJ SMITT PAES

Citation: B. Jansen et al., TC99M-SPECT IN THE DIAGNOSIS OF SKULL BASE METASTASIS, Neurology, 46(2), 1996, pp. 3066-3066